T11363 |
Ganoderic acid F
|
98665-15-7
|
98%
|
|
Ganoderic acid F exhibits antitumor and antimetastatic activities through inhibition of angiogenesis and alteration of proteins involving cell proliferation and/...
|
TN1664 |
Ganoderic acid H
|
98665-19-1
|
|
|
Ganoderic acid H is a potent antitumour agent, it mediates its biological effects through the inhibition of transcription factors AP-1 and NF-kappaB, resulting i...
|
TN1661 |
Ganoderic acid C2
|
103773-62-2
|
|
|
Ganoderic acid C2 has anti-inflammatory,and anti-tumor-promoting activities. Ganoderic acid C2 can inhibit histamine release, it also has inhibitory effects on t...
|
T6S1141 |
Ganoderic acid A
|
81907-62-2
|
98%
|
|
1. Ganoderic acid A exhibits antitumor activity, mediated through its inhibitory effect on nuclear transcription factor-kappaB and activator protein-1. 2. Ganode...
|
TN1879 |
Lucideric acid A
|
95311-94-7
|
98.05%
|
|
Lucideric acid A (Lucidenic acid A) is a modulator of JNK and p38 and enhances LPS-induced immune responses in monocytic THP-1 cells possibly via the modulation ...
|
T5S1133 |
Ganoderic acid D
|
108340-60-9
|
98.06%
|
|
1. Ganoderic acid D is one of the major components in Ganoderma triterpenes. 2. Ganoderic acid D treatment for 48h inhibits the proliferation of HeLa human cervi...
|
T3S1149 |
Ganoderic acid G
|
98665-22-6
|
98.83%
|
|
Ganoderic acid G is isolated from the surface of Ganoderma lucidum tube layer.
|
TN1658 |
Ganoderenic acid D
|
100665-43-8
|
99.05%
|
|
Ganoderenic acid D is a natural product isolated from the effective compounds of Ganoderma lucidum extract (GLE). Ganoderenic acid D induces cell cycle arrest an...
|
TN1059 |
Ganoderic acid B
|
81907-61-1
|
99.95%
|
|
Ganoderic acid B is a chemical marker in quality control of G. lucidum and related products. Ganoderic acid B-containing herbs has potential influence towards th...
|